Merck Paid Elsevier to Publish Phony Peer-Review Journal
Merck is reported to have created a fake "peer-reviewed" journal to present favorable data that made its potentially fatal drugs–Fosamax and Vioxx–look good.
Merck is reported to have created a fake "peer-reviewed" journal to present favorable data that made its potentially fatal drugs–Fosamax and Vioxx–look good.
“Every failure-to-warn case against a drug company has been affected by Wyeth”
The FDA is sliding rapidly down the slippery slope, abandoning widely accepted, international ethical research standards articulated in the internationally accepted, Declaration of Helsinki–to facilitate commercial medical experiments.
AHRP proposes a multi-disciplinary team of independent scientists to review ALL of Dr. Joseph Biederman’s publications and supporting documents, including: research protocols, consent forms, and the original (of course, anonymized) data sets with associated code books for all pediatric studies.
Grassley’s team has asked NAMI to disclose the specifics of its funding so that people with mental illness and their families, as well as the public and healthcare officials, can see for themselves how conflicted this advocacy group is.
"The strategy of big companies when they are dealing with smaller opponents is to stretch the process, to overwhelm us until we are ready to accept whatever they want to offer."
JAMA Editor Ignites Firestorm By Calling Critic a ‘Nobody and a Nothing’_WSJ
"Radical restructuring, not merger mania, is the need of our time." Dr. William Haseltine
Two major cases of medical fraud have undermined patient safety and the integrity of the medico-scientific literature: But how each specialty responded is a study in contrast.
"The corporate death penalty may be appropriate in cases involving recidivist violators, corporations that are deemed to be incapable of reform (i.e. inherently criminogenic)…"
Like their benefactors–drug manufacturers–who violate the law, doctors will be prosecuted in court by the federal government.
Sen. Charles Grassley sent a letter to Pfizer asking the company to provide details of its payments to at least 149 faculty members at Harvard Medical School.